FDA inspection
Jiangsu Guangda Medical Material Group Co., Ltd.: FDA inspection ending Aug 31, 2023
FDA inspection 1217706 · Voluntary Action Indicated (VAI) · Nantong
Key facts
| Inspection ID | 1217706 |
|---|---|
| Firm | Jiangsu Guangda Medical Material Group Co., Ltd. |
| FEI number | 3006847952 |
| Address | Libao, No 18 Baochang North Rd; Libaozhen Haianxian |
| City | Nantong |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Aug 31, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data